Lina Zhang

Nanjing Medical University

H指数:14

被引数:743

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decreased Expression of FAT4 Promotes Multiple Myeloma Proliferation and Migration by Targeting the Hippo/YAP Pathway

FAT4表达下调通过靶向Hippo/YAP通路促进多发性骨髓瘤增殖和迁移

Cancer Science

IF4.3

2026-04-230

Coronary complexity and inflammatory burden in HIV-infected patients with acute coronary syndrome: a two-year prospective cohort study in China

Frontiers in Cardiovascular Medicine

IF2.9

2026-01-260

OAAI

Quercetin induces apoptosis and autophagy in pediatric acute lymphoblastic leukemia by regulating miR-367/KLF4/JNK signaling axis

槲皮素通过调控miR-367/KLF4/JNK信号轴诱导儿童急性淋巴细胞白血病的凋亡和自噬。

LEUKEMIA & LYMPHOMA

IF2.2

2025-12-011

PRE

Beyond monotherapy: multimodal strategies integrating immune checkpoint inhibitors in lymphoma management

超越单药疗法：整合免疫检查点抑制剂的多模式策略在淋巴瘤管理中的应用

Frontiers in Immunology

IF5.9

2025-11-200

OAAI

Case Report: Expanding the spectrum of renal involvement in adult-onset still’s disease: a case of focal proliferative glomerulonephritis and ischemic nephropathy

病例报告：扩大成人斯蒂尔病肾受累谱：一例局灶增生性肾小球肾炎和缺血性肾病

Frontiers in Medicine

IF3

2025-10-160

OAAI

Evaluation of cardiovascular risk according to the 2019 ESC/EASD guidelines in type 1 diabetes mellitus patients: A population-based survey study

根据2019年ESC/EASD指南对1型糖尿病患者的 cardiovascular risk 进行评估：一项基于人群的调查研究

DIABETES RESEARCH AND CLINICAL PRACTICE

IF7.4

2025-07-010

PRE

Gut Microbiota Predicts Treatment Response to Empagliflozin Among MASLD Patients Without Diabetes Mellitus

LIVER INTERNATIONAL

IF5.2

2025-02-140

OAAI

Baseline Gut Microbiota Was Associated with Long-Term Immune Response at One Year Following Three Doses of BNT162b2

VACCINES

IF3.4

2024-08-140

OAAI

Clinical efficacy of CO2 fractional laser combined with compound betamethasone in treating vitiligo and its impact on inflammatory factors

FRONTIERS IN MEDICINE

IF3

2024-07-100

OAAI

Association between Gut Microbiota Composition and Long-Term Vaccine Immunogenicity following Three Doses of CoronaVac

VACCINES

IF3.4

2024-03-272

OAAI

Disitamab Vedotin (RC48) for HER2-positive advanced breast cancer: a case report and literature review

Disitamab Vedotin (RC48) 治疗HER2-positive晚期乳腺癌1例报告并文献复习

FRONTIERS IN ONCOLOGY

IF3.3

2023-11-244

OAAI

Survival trends and prognostic factors for patients with extramedullary plasmacytoma: A population-based study

FRONTIERS IN ONCOLOGY

IF3.3

2022-12-134

OAAI

Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-12-0110

PRE

Cytopenias following anti-CD19 chimeric antigen receptor (CAR) T cell therapy: a systematic analysis for contributing factors

ANNALS OF MEDICINE

IF4.3

2022-11-1622

OAAI

Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma

鉴定多发性骨髓瘤中染色质调节物突变的临床意义和潜在预后模型

CLINICAL EPIGENETICS

IF4.4

2022-07-235

OAAI

Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma

复发或难治性多发性骨髓瘤中抗BCMA嵌合抗原受体T细胞疗法的综合荟萃分析

ANNALS OF MEDICINE

IF4.3

2021-08-3025

OAAI

Treatment Outcomes of Clopidogrel in Patients With ACS and Diabetes Undergoing PCI-Analysis of Beijing Municipal Medical Insurance Database

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2021-07-304

OAAI

Cardioprotective effect of anisodamine against ischemia/reperfusion injury through the mitochondrial ATP-sensitive potassium channel

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2021-06-0115

PRE

Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy

hematology oncology

IF13.5

2021-02-1934

OAAI

hUCMSC-extracellular vesicles downregulated hepatic stellate cell activation and reduced liver injury in S. japonicum-infected mice

STEM CELL RESEARCH & THERAPY

IF7.3

2020-01-0953

OAAI

Lina Zhang

个人简介

教育背景

工作经历

荣誉奖项

研究方向